SUBSCRIBERS

Hyphens Pharma prices IPO at S$0.26 a share to raise S$13.5m

The company made a net profit of S$6m in 2017, up 16% from 2016 as revenue rose 12% to S$113m

Published Fri, May 11, 2018 · 09:50 PM

Singapore

HYPHENS Pharma International, which sells specialty pharmaceutical products, is seeking to raise S$13.5 million in net proceeds ahead of a listing on the Singapore Exchange's (SGX) Catalist board.

Hyphens is offering a total of 29.6 million shares (9.9 per cent of the company) at S$0.26 apiece. Cornerstone investors will take up another 10.1 per cent stake in Hyphens.